A new parasympathomimetic agent: 1-methyl-5-chloroindoline methylbromide.
D000009:Abdominal Muscles / Q000187:drug effects; D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001001:Anura; D001285:Atropine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010648:Phenylacetates / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D010851:Picrates / Q000494:pharmacology; D011343:Procaine / Q000494:pharmacology; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D007211:Indoles; D010277:Parasympathomimetics; D010648:Phenylacetates; D010851:Picrates; D000644:Quaternary Ammonium Compounds; D011343:Procaine; D009538:Nicotine; D009020:Morphine; D001285:Atropine; D010830:Physostigmine; D000109:Acetylcholine; D014403:Tubocurarine